AI foundation model company Bioptimus has raised a further $41 million cash injection, bringing its funding to $76 million.
Bioptimus is redefining how we approach biological research by addressing a longstanding issue: the siloed nature of biological understanding.
Historically, research has focused on isolated biological components, such as DNA, proteins, cells or tissues. Even existing AI foundation models operate within these silos, limiting their potential impact.